09.16.11
Sentio LLC has opened a new research and development center in Southfield, Mich. The new facility is part of the company's effort to expand its pool of engineering talent as well as enhance Southeast Michigan’s R&D capabilities for the medical device market.
The new R&D center in will focus on new technologies for intra-operative nerve monitoring (IONM). The first phase will include electronic and software laboratories. Phase two of the expansion will add hardware prototyping capabilities and is expected to be up and running by the end of the year.
“We are very excited about the expansion of Sentio’s research and development activities in Southeast Michigan, including the establishment of the new R&D center in Southfield. This will speed the pace at which our partners bring a greater breadth and depth to the rapidly growing IONM market,” said Chris Wybo, chief operating officer for Sentio. “The creation of this new R&D center in Southfield greatly contributes to Sentio’s innovation ability.
The company's leadership is focused on transforming Michigan's industrial expertise into growth for 21st century technologies such as biomedical and medical technologies.
"Southeast Michigan has the capability of becoming a leader in the development of medical devices. An entrepreneurial spirit combined with strong engineering talent and leading edge medical research creates a perfect environment for new product development. Our goal was to establish a facility where new ideas and creative solutions can flourish,” said Stephen Bartol, president and CEO of Sentio. “We are confident that our R&D center in Southfield will help drive continued innovation of smart sensor solutions by leveraging the expertise of local companies and the talent of our exceptional employees.”
In June this year, Sentio launched its first platform, SentioMMG, a nerve-mapping tool that allows surgeons to locate and identify nerves during surgery with the goal of making minimally invasive surgery much safer.
“It is the first smart sensor to be used for nerve monitoring in surgery and initial sales have been targeted at the lucrative and rapidly growing minimally invasive spine surgery market," Bartol said.
Headquartered in Southfield, Mich., Sentio is a privately held company.
The new R&D center in will focus on new technologies for intra-operative nerve monitoring (IONM). The first phase will include electronic and software laboratories. Phase two of the expansion will add hardware prototyping capabilities and is expected to be up and running by the end of the year.
“We are very excited about the expansion of Sentio’s research and development activities in Southeast Michigan, including the establishment of the new R&D center in Southfield. This will speed the pace at which our partners bring a greater breadth and depth to the rapidly growing IONM market,” said Chris Wybo, chief operating officer for Sentio. “The creation of this new R&D center in Southfield greatly contributes to Sentio’s innovation ability.
The company's leadership is focused on transforming Michigan's industrial expertise into growth for 21st century technologies such as biomedical and medical technologies.
"Southeast Michigan has the capability of becoming a leader in the development of medical devices. An entrepreneurial spirit combined with strong engineering talent and leading edge medical research creates a perfect environment for new product development. Our goal was to establish a facility where new ideas and creative solutions can flourish,” said Stephen Bartol, president and CEO of Sentio. “We are confident that our R&D center in Southfield will help drive continued innovation of smart sensor solutions by leveraging the expertise of local companies and the talent of our exceptional employees.”
In June this year, Sentio launched its first platform, SentioMMG, a nerve-mapping tool that allows surgeons to locate and identify nerves during surgery with the goal of making minimally invasive surgery much safer.
“It is the first smart sensor to be used for nerve monitoring in surgery and initial sales have been targeted at the lucrative and rapidly growing minimally invasive spine surgery market," Bartol said.
Headquartered in Southfield, Mich., Sentio is a privately held company.